BIOCHEMICAL PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

17小时前 科研小白i 来自江苏省

4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-01-23 12346694m83(暂无昵称) 来自浙江省

偏重的研究方向：肿瘤
经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？

33 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-01-16 ms5000001598335110 来自湖南省

投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。

19 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2023-05-08 ms3000001240185836 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：心血管疾病
经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。

45 26

展开26条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-05-09 ms6000002080703872 来自江苏省

有没有已经有三个审稿人还在邀请评审专家的

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-04-12 ms6000002080703872 来自江苏省

这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-04-24 xgwan123 来自辽宁省

到编辑那里第一台就Decision in Process，已经凉凉了

6 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-01-23 ms9000001327347856 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：黏附分子;胃癌
经验分享：已经外审12周了，窒息了

188 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-03-07 ms4000000706495698 来自上海

审稿速度:3.0 | 投稿命中率:50.0
经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。

16 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2207788, encodeId=aef3220e7886f, content=4月中旬送外审 5月28显示外审完成 5月30显示DIP 6月1 仍旧是DIP, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210531/5f7cf98bc3ff42f9bdb3c8abf4b519fe/43510175e95b4dddbccc3b11e600cae0.jpg, createdBy=3c742286789, createdName=科研小白i, createdTime=Sat Jun 01 16:36:24 CST 2024, time=17小时前, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183371, encodeId=368621833e1d5, content=偏重的研究方向：肿瘤 经验分享：审稿人意见返回编辑那里有三周了，状态依然是Decision in Process，编辑一直不做决定，有没有人遇到过呢？可以发邮件催一下吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=023d2396907, createdName=12346694m83(暂无昵称), createdTime=Tue Jan 23 09:38:03 CST 2024, time=2024-01-23, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2181993, encodeId=a44d21819936e, content=投稿后第四天变成了DIP，目前一周多了，发邮件给编辑也没反应，要拒也给我个准信呀。科研人时间上的无奈呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06d55411127, createdName=ms5000001598335110, createdTime=Tue Jan 16 15:58:49 CST 2024, time=2024-01-16, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203602, encodeId=b30c2203602ca, content=有没有已经有三个审稿人还在邀请评审专家的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Thu May 09 09:28:05 CST 2024, time=2024-05-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2198105, encodeId=f3d8219810549, content=这个期刊不是说很快吗，投了10天，5天才到编辑那。现在在编辑那又呆了5天。着急毕业呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3de09226196, createdName=ms6000002080703872, createdTime=Fri Apr 12 09:34:50 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2200181, encodeId=320a2200181c2, content=到编辑那里第一台就Decision in Process，已经凉凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d76a5530891, createdName=xgwan123, createdTime=Wed Apr 24 19:40:05 CST 2024, time=2024-04-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2183494, encodeId=13e621834949b, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：黏附分子;胃癌 经验分享：已经外审12周了，窒息了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Tue Jan 23 20:06:15 CST 2024, time=2024-01-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2191733, encodeId=010b2191e33e4, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：求问有没有朋友碰到只有一个审稿意见就DIP了？因为第二个审稿人找了一个多月还找不到，今天看已经review complete了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9e446571671, createdName=ms4000000706495698, createdTime=Thu Mar 07 11:03:01 CST 2024, time=2024-03-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2201126, encodeId=93202201126af, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43f25182301, createdName=146fc4d4m73暂无昵称, createdTime=Mon Apr 29 20:06:18 CST 2024, time=2024-04-29, status=1, ipAttribution=上海)]

2024-04-29 146fc4d4m73暂无昵称来自上海

审稿速度:1.0 | 投稿命中率:5.0
经验分享：垃圾期刊，官网说做第一个决定是3天，未经审稿，现在投稿第23天显示正在做决定，下一步应该就是拒稿了，真服了，拒稿需要等超过23天吗？垃圾编辑，永不再投稿！

11 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务